Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
The development of resistance is a problem shared by both classical chemotherapy and targeted therapy. Patients may respond well at first, but relapse is inevitable for many cancer patients, despite many improvements in drugs and their use over the last 40 years. |